What is NeoGenomics's total equity?

NeoGenomics (NEO) reported total equity of $828.76M in Q1 2026.

How has NeoGenomics's total equity changed year-over-year?

NeoGenomics's total equity decreased by 6.7% year-over-year, from $888.27M to $828.76M.

What is the long-term trend for NeoGenomics's total equity?

Over 5 years (2020 to 2025), NeoGenomics's total equity has grown at a 3.8% compound annual growth rate (CAGR), from $694.29M to $836.56M.

What does total equity mean?

Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.

NeoGenomics NEO Total Equity

Total Equity at other companies

Labcorp HoldingsLH

$8.73B+5.1%

Quest DiagnosticsDGX

$7.37B+6.3%

Personalis, Inc.PSNL

$254.77M+22.9%

Guardant HealthGH

-$181.07M+27.8%

Natera, Inc.NTRA

$1.77B+43.1%

Tempus AI, Inc.TEM

$416.41M+27.7%

Other financials

Income statement

See full

Revenue$186.7M+11.1%

Gross profit$80.9M+10.4%

Operating income-$18.2M+34.4%

Net income-$17.1M+34.0%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$146.1M-57.8%

Total debt$66.3M+5.3%

Total assets$1.3B-15.9%

Cash flow

See full

Operating cash flow-$8.1M+67.9%

CapEx$5.0M+11.1%

Free cash flow-$13.1M+56.0%

Valuation

See full

Market cap$1.68B+86.5%

Enterprise value$1.6B+159%

P/S2.3×+0.9×

Profitability

See full

Gross margin43.2%-1.1pp

Operating margin-14.2%+1.1pp

Net margin-13.3%+2.4pp

FCF margin-4.9%—

Returns & leverage

See full

Return on equity-11.6%+6.2pp

Debt / equity0.1×0.0×

Current ratio4.4×+2.4×

Where this comes from

Reported directly by NeoGenomics in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: NeoGenomics’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about NeoGenomics's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NeoGenomics's total equity?: NeoGenomics (NEO) reported total equity of $828.76M in Q1 2026.
How has NeoGenomics's total equity changed year-over-year?: NeoGenomics's total equity decreased by 6.7% year-over-year, from $888.27M to $828.76M.
What is the long-term trend for NeoGenomics's total equity?: Over 5 years (2020 to 2025), NeoGenomics's total equity has grown at a 3.8% compound annual growth rate (CAGR), from $694.29M to $836.56M.
What does total equity mean?: Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.